Want to join the conversation?
$CSX 2Q15 Q&A Update – Fredrik, CFO: On productivity and efficiency gains, we’ve gone enough to good start this year, $45MM in the 2Q15 and by $41MM in 1Q15. We still think we can approach $200MM for the full year, but probably not as close as we originally had thought. We are very much focused on driving efficiency gains.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.